Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth
Source: SeekingAlpha
2026-03-17 23:59:41 ET
Investment Overview
I am re-initiating coverage on Strata Critical Medical ( SRTA ) with a “ Buy ” rating and an investment horizon of 12 to 24 months. I believe that SRTA stock is attractively valued and poised to trend higher within the investment horizon. This coverage discusses the factors to be bullish with a focus on the company’s fundamentals, industry tailwinds, and the valuation metrics....
Read the full article on Seeking Alpha
For further details see:
Strata Critical Medical: Significant Upside Potential Backed By Robust EBITDA Growth
Strata Critical Medical Inc.
NASDAQ: SRTA
SRTA Trading
-1.59% G/L:
$4.015 Last:
236,180 Volume:
$4.06 Open:
SRTA Latest News
April 09, 2026 05:11:28 pm
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
